Jane Street’s Nanobiotix NBTX Stock Holding History

Jane Street’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,387	Closed	-$40.8K	–	10448
2025 Q1	$40.8K	Sell	11,387 -11,896	-51%	-$41.1K	﹤0.01%	9047
2024 Q4	$72.9K	Buy	+23,283	New	+$93.2K	﹤0.01%	8872

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Jane Street's NBTX Position: Q2 2025 in Review

Jane Street sold out of Nanobiotix (NBTX) in Q2 2025, closing a stake of 11,387 shares — an estimated $40.8K sold.

Jane Street first reported a position in NBTX in Q4 2024 and held it in 2 quarters. The position peaked at $72.9K in Q4 2024. 10 funds tracked by Wall St. Rank hold NBTX as of Q2 2025.

Jane Street reported no remaining Nanobiotix position as of Q2 2025 after selling out during the quarter.
Jane Street sold 11,387 Nanobiotix shares in Q2 2025, an estimated $40.8K.
Jane Street first reported a position in Nanobiotix in Q4 2024 and held it in 2 quarters.
Jane Street's Nanobiotix position peaked at $72.9K in Q4 2024.
10 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.